Alert: New Earnings Report (11/8/23)-Amicus Therapeutics Inc (NASDAQ: FOLD).
Amicus Therapeutics Inc (NASDAQ: FOLD) has reported E.P.S. of $-0.07 for its third fiscal quarter (ending September 30) versus $-0.12 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]